BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 26098610)

  • 1. Effects of thymosin β4 and its N-terminal fragment Ac-SDKP on TGF-β-treated human lung fibroblasts and in the mouse model of bleomycin-induced lung fibrosis.
    Conte E; Iemmolo M; Fruciano M; Fagone E; Gili E; Genovese T; Esposito E; Cuzzocrea S; Vancheri C
    Expert Opin Biol Ther; 2015; 15 Suppl 1():S211-21. PubMed ID: 26098610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive and therapeutic effects of thymosin β4 N-terminal fragment Ac-SDKP in the bleomycin model of pulmonary fibrosis.
    Conte E; Fagone E; Gili E; Fruciano M; Iemmolo M; Pistorio MP; Impellizzeri D; Cordaro M; Cuzzocrea S; Vancheri C
    Oncotarget; 2016 Jun; 7(23):33841-54. PubMed ID: 27029074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-inflammatory peptide Ac-SDKP is released from thymosin-β4 by renal meprin-α and prolyl oligopeptidase.
    Kumar N; Nakagawa P; Janic B; Romero CA; Worou ME; Monu SR; Peterson EL; Shaw J; Valeriote F; Ongeri EM; Niyitegeka JM; Rhaleb NE; Carretero OA
    Am J Physiol Renal Physiol; 2016 May; 310(10):F1026-34. PubMed ID: 26962108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A long-acting isomer of Ac-SDKP attenuates pulmonary fibrosis through SRPK1-mediated PI3K/AKT and Smad2 pathway inhibition.
    Qiu Y; Wang Z; Zhang X; Huang P; Zhang W; Zhang K; Wang S; He L; Guo Y; Xiang A; Zhang C; Hao Q; Li M; Li W; Zhang Y
    IUBMB Life; 2020 Dec; 72(12):2611-2626. PubMed ID: 33135306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of N-acetyl-seryl-aspartyl-lysyl-proline on differentiation from pulmonary fibroblast to myofibroblast mediated by Rho-associated coiled-coil forming protein kinase pathway].
    Yuan Y; Yang F; Xu H; Yu WY; Sun Y; Deng HJ; Ma WD; Wei ZQ; Wang RM
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2013 Sep; 31(9):654-60. PubMed ID: 24064119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymosin β4 reduces IL-17-producing cells and IL-17 expression, and protects lungs from damage in bleomycin-treated mice.
    Conte E; Iemmolo M; Fagone E; Gili E; Fruciano M; Genovese T; Esposito E; Cuzzocrea S; Vancheri C
    Immunobiology; 2014 Jun; 219(6):425-31. PubMed ID: 24613476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymosin β4 and its degradation product, Ac-SDKP, are novel reparative factors in renal fibrosis.
    Zuo Y; Chun B; Potthoff SA; Kazi N; Brolin TJ; Orhan D; Yang HC; Ma LJ; Kon V; Myöhänen T; Rhaleb NE; Carretero OA; Fogo AB
    Kidney Int; 2013 Dec; 84(6):1166-75. PubMed ID: 23739235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New anti-fibrotic mechanisms of n-acetyl-seryl-aspartyl-lysyl-proline in silicon dioxide-induced silicosis.
    Sun Y; Yang F; Yan J; Li Q; Wei Z; Feng H; Wang R; Zhang L; Zhang X
    Life Sci; 2010 Aug; 87(7-8):232-9. PubMed ID: 20624403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of thymosin β4 in a mouse model of lung fibrosis.
    Conte E; Genovese T; Gili E; Esposito E; Iemmolo M; Fruciano M; Fagone E; Pistorio MP; Crimi N; Cuzzocrea S; Vancheri C
    Ann N Y Acad Sci; 2012 Oct; 1269():69-73. PubMed ID: 23045972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ac-SDKP increases α-TAT 1 and promotes the apoptosis in lung fibroblasts and epithelial cells double-stimulated with TGF-β1 and silica.
    Shifeng L; Hong X; Xue Y; Siyu N; Qiaodan Z; Dingjie X; Lijuan Z; Zhongqiu W; Xuemin G; Wenchen C; Guizhen Z; Dan L; Ruimin W; Fang Y
    Toxicol Appl Pharmacol; 2019 Apr; 369():17-29. PubMed ID: 30826375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Tβ4-POP-Ac-SDKP Axis in Organ Fibrosis.
    Wang W; Jia W; Zhang C
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymosin β4 protects C57BL/6 mice from bleomycin-induced damage in the lung.
    Conte E; Genovese T; Gili E; Esposito E; Iemmolo M; Fruciano M; Fagone E; Pistorio MP; Crimi N; Cuzzocrea S; Vancheri C
    Eur J Clin Invest; 2013 Mar; 43(3):309-15. PubMed ID: 23320620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new antifibrotic target of Ac-SDKP: inhibition of myofibroblast differentiation in rat lung with silicosis.
    Xu H; Yang F; Sun Y; Yuan Y; Cheng H; Wei Z; Li S; Cheng T; Brann D; Wang R
    PLoS One; 2012; 7(7):e40301. PubMed ID: 22802960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymosin β4 Suppresses LPS-Induced Murine Lung Fibrosis by Attenuating Oxidative Injury and Alleviating Inflammation.
    Tian Z; Yao N; Wang F; Ruan L
    Inflammation; 2022 Feb; 45(1):59-73. PubMed ID: 34414534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ac-SDKP inhibits transforming growth factor-beta1-induced differentiation of human cardiac fibroblasts into myofibroblasts.
    Peng H; Carretero OA; Peterson EL; Rhaleb NE
    Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1357-64. PubMed ID: 20154264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of Ac-SDKP on alveolar epithelial cells through inhibition of EMT via TGF-β1/ROCK1 pathway in silicosis in rat.
    Deng H; Xu H; Zhang X; Sun Y; Wang R; Brann D; Yang F
    Toxicol Appl Pharmacol; 2016 Mar; 294():1-10. PubMed ID: 26785300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylated α-Tubulin Regulated by N-Acetyl-Seryl-Aspartyl-Lysyl-Proline(Ac-SDKP) Exerts the Anti-fibrotic Effect in Rat Lung Fibrosis Induced by Silica.
    Xiaojun W; Yan L; Hong X; Xianghong Z; Shifeng L; Dingjie X; Xuemin G; Lijuan Z; Bonan Z; Zhongqiu W; Ruimin W; Brann D; Fang Y
    Sci Rep; 2016 Aug; 6():32257. PubMed ID: 27577858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
    Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
    Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tβ4-Ac-SDKP pathway: Any relevance for the cardiovascular system?
    Kassem KM; Vaid S; Peng H; Sarkar S; Rhaleb NE
    Can J Physiol Pharmacol; 2019 Jul; 97(7):589-599. PubMed ID: 30854877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of thymosin-beta4 and its derivative N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) in cardiac healing after infarction.
    Cavasin MA
    Am J Cardiovasc Drugs; 2006; 6(5):305-11. PubMed ID: 17083265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.